Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
105,000
Total Value
$0.00
P&L
+inf% (+$1,409,100.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 105,000 | $0.00 | $0.00 | 105,000 | Direct | โ | View Details |